Vaspin gene changes and blood vaspin levels in people with psoriasis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational, cross-sectional study at Aswan University Hospital will enroll patients with psoriasis to measure serum vaspin levels and to genotype vaspin gene polymorphisms (SERPNA12). Blood samples will be taken for serum protein measurement and DNA analysis, and clinical information including treatment history will be recorded. Eligible participants are newly diagnosed patients or those off treatment for at least six months, while individuals with pregnancy, lactation, chronic systemic disease, malignancy, or other inflammatory conditions are excluded. Data analysis will look for correlations between genotype variants, serum vaspin concentrations, and clinical features of psoriasis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Newly diagnosed cases or stopped treatment of at least 6 months of psoriasis patients.
* Pateints with any age and gender.

Exclusion Criteria:

* Pregnancy and lactation.
* Patients with chronic diseases: cardiac diseases, hepatic disorders, chronic renal failure or malignancies.
* Patients with associated inflammatory disease such as infections and autoimmune diseases.

Where it's running

• Aswan University Hospital
  Aswān, Egypt Recruiting

Study contacts

• Study coordinator: Ola Mahmoud Samy Mohamed, MSC
• Email: olaelqousy@gmail.com
• Phone: +201025592922

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• HRS-4139 safety and pharmacology in healthy adults

  This early-phase study tests a single dose of HRS-4139 to see if it is safe and how the body handles it in healthy adults aged 18–55.

  Recruiting Phase 1 Fujian Shengdi Pharmaceutical Co., Ltd. · Changsha, Hunan · NCT07802964

• Total Coumarin botanical cream for psoriasis vulgaris

  This trial will try a botanical Total Coumarin cream applied twice daily for 8 weeks to see if it helps adults with mild to moderate psoriasis.

  Recruiting Phase 3 Psoriasis Research Institute of Guangzhou · New York, New York · NCT07426120

• Topical diacerein in plaque psoriasis (adult) explores if a cream helps skin improve

  This trial tests whether applying a topical diacerein cream twice daily for 8 weeks helps adults with mild-to-moderate psoriasis vulgaris improve symptoms more than a placebo.

  Recruiting Phase 4 Cairo University · Cairo · NCT07352306

• Optimizing biologic dosing for psoriasis treatment

  This study is testing if a new way of adjusting psoriasis medication based on blood tests can work just as well as the usual method over 18 months.

  Recruiting at 10 sites Phase 4 University Hospital, Ghent · Bruges and 14 other locations · NCT06398106

• Treatment of psoriasis with deucravacitinib

  This study is testing how well a new medication called deucravacitinib can change immune cell behavior in people with moderate to severe psoriasis.

  Recruiting Phase 4 University of California, San Francisco · San Francisco, California · NCT05858645

• Shuiniujiao Dihuang Decoction With Variation for Psoriasis

  A 12-week study tests whether the Chinese medicine formula Shuiniujiao Dihuang Decoction with Variation can help people with mild to moderate plaque psoriasis compared with placebo.

  Recruiting Phase 2 Chinese University of Hong Kong · Hong Kong · NCT05815797

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.